GB2621755A - Liquid cleansing composition - Google Patents
Liquid cleansing composition Download PDFInfo
- Publication number
- GB2621755A GB2621755A GB2317800.7A GB202317800A GB2621755A GB 2621755 A GB2621755 A GB 2621755A GB 202317800 A GB202317800 A GB 202317800A GB 2621755 A GB2621755 A GB 2621755A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- acid
- hydroxysultaine
- amphoteric surfactant
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 90
- 239000007788 liquid Substances 0.000 title claims abstract description 25
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 43
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 39
- 229940061720 alpha hydroxy acid Drugs 0.000 claims abstract description 15
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 24
- 241000209140 Triticum Species 0.000 claims description 20
- 235000021307 Triticum Nutrition 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 18
- -1 pH adjusters Substances 0.000 claims description 17
- 239000011734 sodium Substances 0.000 claims description 14
- 229910052708 sodium Inorganic materials 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 11
- 235000014655 lactic acid Nutrition 0.000 claims description 11
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 claims description 10
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 9
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 8
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003974 emollient agent Substances 0.000 claims description 6
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 6
- 229960002510 mandelic acid Drugs 0.000 claims description 6
- 239000002736 nonionic surfactant Substances 0.000 claims description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 5
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 5
- 239000002304 perfume Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- MCNJOIMMYWLFBA-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCOC(=O)CS(O)(=O)=O MCNJOIMMYWLFBA-UHFFFAOYSA-N 0.000 claims description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000003906 humectant Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- ONYHQNURMVNRJZ-QXMHVHEDSA-N 3-[3-[[(Z)-docos-13-enoyl]amino]propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O ONYHQNURMVNRJZ-QXMHVHEDSA-N 0.000 claims description 2
- QDDVYXATFUPZBK-UHFFFAOYSA-N 3-[dimethyl-[3-(tetradecanoylamino)propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O QDDVYXATFUPZBK-UHFFFAOYSA-N 0.000 claims description 2
- CNIGBCBFYDWQHS-QXMHVHEDSA-N 3-[dimethyl-[3-[[(z)-octadec-9-enoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O CNIGBCBFYDWQHS-QXMHVHEDSA-N 0.000 claims description 2
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical group OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000006172 buffering agent Substances 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000003752 hydrotrope Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical group OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 229940074928 isopropyl myristate Drugs 0.000 claims 1
- 239000003605 opacifier Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 24
- 238000009472 formulation Methods 0.000 description 20
- 235000018102 proteins Nutrition 0.000 description 18
- 239000000344 soap Substances 0.000 description 17
- 230000003115 biocidal effect Effects 0.000 description 12
- 239000002253 acid Substances 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 125000002091 cationic group Chemical group 0.000 description 8
- 150000007524 organic acids Chemical class 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 7
- 238000005187 foaming Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 125000000129 anionic group Chemical group 0.000 description 6
- 229940093915 gynecological organic acid Drugs 0.000 description 6
- 235000005985 organic acids Nutrition 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 239000003139 biocide Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000002843 carboxylic acid group Chemical group 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 3
- 230000002939 deleterious effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 208000033316 Acquired hemophilia A Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- OQWIKYXFAZAALW-FMDYKLJDSA-N (2S)-2-amino-5-oxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid Chemical compound N[C@@H](CCC(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(O)=O OQWIKYXFAZAALW-FMDYKLJDSA-N 0.000 description 1
- QZWWLBNHCDXKFW-XRJQKLFWSA-N (2r,3r,4r,5s)-6-[2-hydroxyoctadecyl(methyl)amino]hexane-1,2,3,4,5-pentol Chemical compound CCCCCCCCCCCCCCCCC(O)CN(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO QZWWLBNHCDXKFW-XRJQKLFWSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- LPMBTLLQQJBUOO-KTKRTIGZSA-N (z)-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(CCO)CCO LPMBTLLQQJBUOO-KTKRTIGZSA-N 0.000 description 1
- UDZAXLGLNUMCRX-KHPPLWFESA-N (z)-n-(2-hydroxypropyl)octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCC(C)O UDZAXLGLNUMCRX-KHPPLWFESA-N 0.000 description 1
- PDVQCPFKYPYROG-ZDKIGPTLSA-N (z,12r)-12-hydroxy-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)N(CCO)CCO PDVQCPFKYPYROG-ZDKIGPTLSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- KZVIUXKOLXVBPC-UHFFFAOYSA-N 16-methylheptadecanamide Chemical compound CC(C)CCCCCCCCCCCCCCC(N)=O KZVIUXKOLXVBPC-UHFFFAOYSA-N 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- OLQJQHSAWMFDJE-UHFFFAOYSA-N 2-(hydroxymethyl)-2-nitropropane-1,3-diol Chemical compound OCC(CO)(CO)[N+]([O-])=O OLQJQHSAWMFDJE-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- AKWFJQNBHYVIPY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO AKWFJQNBHYVIPY-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 1
- RJQQOKKINHMXIM-UHFFFAOYSA-N 2-hydroxypropanoate;tris(2-hydroxyethyl)azanium Chemical compound CC(O)C(O)=O.OCCN(CCO)CCO RJQQOKKINHMXIM-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- IREAODMQYCOAGP-UHFFFAOYSA-N 3-(hexadecanoylamino)propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)C IREAODMQYCOAGP-UHFFFAOYSA-N 0.000 description 1
- UCNXEGMKUYUZIW-UHFFFAOYSA-N 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol dodecanoic acid Chemical compound CC1=C(O)C(CO)=C(CO)C=N1.CCCCCCCCCCCC(O)=O UCNXEGMKUYUZIW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- WHDZFABLYCTYDP-UHFFFAOYSA-N 5-oxopyrrolidine-2-carboxylate;tris(2-hydroxyethyl)azanium Chemical compound OC(=O)C1CCC(=O)N1.OCCN(CCO)CCO WHDZFABLYCTYDP-UHFFFAOYSA-N 0.000 description 1
- 241001139376 Allas Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000194029 Enterococcus hirae Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000841267 Homo sapiens Long chain 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 102100029107 Long chain 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- OTGQIQQTPXJQRG-UHFFFAOYSA-N N-(octadecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCO OTGQIQQTPXJQRG-UHFFFAOYSA-N 0.000 description 1
- JHIXEZNTXMFXEK-UHFFFAOYSA-N N-(tetradecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCC(=O)NCCO JHIXEZNTXMFXEK-UHFFFAOYSA-N 0.000 description 1
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920002507 Poloxamer 124 Polymers 0.000 description 1
- 229920002517 Poloxamer 338 Polymers 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- JHSNLCCMZMGXLK-UHFFFAOYSA-N [3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COCC(O)CO JHSNLCCMZMGXLK-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 229940096362 cocoamphoacetate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002195 fatty ethers Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940088638 glycereth-7 Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- GTABBGRXERZUAH-UHFFFAOYSA-N hexadecan-1-ol;2-methyloxirane;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCCCCCCCCCCO GTABBGRXERZUAH-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229910052806 inorganic carbonate Inorganic materials 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 229910052920 inorganic sulfate Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940035535 iodophors Drugs 0.000 description 1
- 229940113096 isoceteth 20 Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940102253 isopropanolamine Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940116335 lauramide Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- JJYKJUXBWFATTE-UHFFFAOYSA-N mosher's acid Chemical compound COC(C(O)=O)(C(F)(F)F)C1=CC=CC=C1 JJYKJUXBWFATTE-UHFFFAOYSA-N 0.000 description 1
- XHUUHJFOYQREKL-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)-16-methylheptadecanamide Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)N(CCO)CCO XHUUHJFOYQREKL-UHFFFAOYSA-N 0.000 description 1
- BPXGKRUSMCVZAF-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)decanamide Chemical compound CCCCCCCCCC(=O)N(CCO)CCO BPXGKRUSMCVZAF-UHFFFAOYSA-N 0.000 description 1
- XGZOMURMPLSSKQ-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCO XGZOMURMPLSSKQ-UHFFFAOYSA-N 0.000 description 1
- SKDZEPBJPGSFHS-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(CCO)CCO SKDZEPBJPGSFHS-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940037624 palmitamidopropyltrimonium chloride Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000013503 personal care ingredient Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000012994 photoredox catalyst Substances 0.000 description 1
- 229940093448 poloxamer 124 Drugs 0.000 description 1
- 229940044476 poloxamer 407 Drugs 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940094944 saccharide isomerate Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940095696 soap product Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical group [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 229940100458 steareth-21 Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- RXSHXLOMRZJCLB-UHFFFAOYSA-L strontium;diacetate Chemical compound [Sr+2].CC([O-])=O.CC([O-])=O RXSHXLOMRZJCLB-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229940062461 triethanolamine lactate Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a liquid cleansing composition comprising at least one alpha hydroxy acid, at least one anionic surfactant and at least one amphoteric surfactant, wherein the at least one amphoteric surfactant comprises a sultaine group. The at least one anionic surfactant and the at least one amphoteric surfactant are present in an amount of 3-20 % w/w, and the ratio of the at least one anionic surfactant to the at least one amphoteric surfactant is 2:1 or greater.
Description
Liquid Cleansing Composition The invention relates to a liquid cleansing composition, in particular to a biocidal hand washing composition for frequent handwashing purposes.
Background to the Invention
There is a desire for skin cleansing products, and particularly hand soaps, to have a biocidal action. That is to say a hand soap product comprising a chemical substance or microorganism intended to destroy, deter, render harmless, or exert a controlling effect on any harmful organism. The need is greatest in industries which handle food and in healthcare, but increasingly as viruses have become more common, such as SARS, MERS and SARS-Cov-2, there is also a requirement for these products amongst consumers Liquid hand soaps are commonly based on either a traditional soap, i.e. a fatty acid neutralised with a common alkali such as potassium hydroxide, or based on an anionic surfactant. The anionic surfactant is normally sodium laureth sulphate, sodium lauryl sulphate, or the corresponding potassium and amine salts of these sulphates. Such soaps do not have the desired efficacy in eliminating pathogens in the short contact times associated with handwashing.
The simple addition of a biocide to an existing hand soap unfortunately does not produce the desired results. The most commonly used biocidal active substances, such as quaternary ammonium compounds and biguanides, lose their efficacy in the presence of soap and anionic surfactants. Reactive biocides, such as sodium hypochlorite, iodophors and hydrogen peroxide also tend to have limited compatibility with the substances commonly found in soaps and are considered to be too harsh on the skin for common use. Phenolic compounds, such as chloroxylenol, have been used in hand soaps but their harsh smell has limited their use. Triclosan was commonly used until environmental concerns curtailed it's use.
Of the remaining biocides, organic acids have found some favour in these products. Many organic acids are known to possess biocidal properties In particular, the ones which have proven to be most useful for disinfection and with reasonable skin compatibility to make them useful in personal care applications are the alpha hydroxyl acids, commonly known as AHAs Of those AHAs, most interest for biocidal formulations has fallen on lactic and glycolic acid It is known that the most common anionic surfactants, sodium lauryl sulphate and sodium lauryl ether sulphate, have a synergistic action with AllAs. As such it appears plausible that formulating a suitable biocidal hand soap conforming to EN 1276 should be possible. EN 1276 is the 60-second British and European quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas. This is exemplified and discussed further in "L-Lactic Acid -A Safe Antimicrobial for Home and Personal Care Lornndations" to Boomsma, B. et a/ in SOFW Journal: Home & Personal Care Ingredients & Formulations (2015), Vol. 10, No.141, pp.2-5.
However, such an assumption is misleading Biocidal hand soaps are by their very nature used in areas which require frequent handwashing, such as in food preparation or healthcare.
This necessitates a very mild product with pleasant foaming characteristics to encourage frequent use and distribute the product efficiently in a volume of space, such as over the hands. Anionic surfactants in isolation have a relatively high irritation potential which, coupled with the inherent irritation potential of an acidic formulation, render such simplistic formulations unsatisfactory in the commercial environment.
It is commonly known for soaps without biocidal action that both the irritation potential and the foaming characteristics of anionic surfactants can be simultaneously improved by the addition of amphoteric surfactants, principally cocamidopropyl betaine.
This presents a problem. In attempting to make the formulation mild by the addition of amphoteric surfactant, the formulator has inhibited the efficacy of the lactic acid/anionic surfactant combination and thus needs to reformulate at a more aggressive pH to compensate for the reduction in efficacy. This antagonism renders such a formulation approach ineffective.
W02018/022016A1 discloses a liquid cleansing composition which includes a cleansing component and an antibacterial system. The antibacterial system includes an antibacterial agent and an antibacterial enhancing agent, wherein the weight ratio of the antibacterial agent to the antibacterial enhancing agent is greater than or equal to 0.30:1 and less than or equal to 0.65:1, wherein the suitability of the composition was tested in accordance with European Standard NF EN 1040 having a sixty-minute evaluation timeframe, which is incompatible with compositions suitable for frequent handwashing purposes.
Other the relevant prior art includes US 7,544,366; W02017/174675, US 2011/0142965; and W02011/163463. W02017/174675 discloses tauraines in combination with sultaines with optional additional components, not disclosed in combination, taken from separate extensive list, those lists including specific copolymerised wheat derivatives and citric acid.
There remains a need for a fast-acting, mild, skin cleansing preparation with substantial biocidal efficacy, such as the ability to pass EN 1276. There remains a need for a fast-acting, high foaming, skin cleansing preparation with substantial biocidal efficacy, such as the ability to pass EN 1276 A combination of mildness and foaming would be even more beneficial
Summary of the Invention
The invention is set out in accordance with the appended claims. The invention relates to a liquid cleansing composition comprising at least one alpha hydroxy acid, at least one anionic surfactant, and at least one amphoteric surfactant wherein the at least one amphoteric surfactant comprises a sultaine group.
Formulations according to the invention have antiviral properties, and may be produced in the form of antibacterial soaps or hand dishwashing liquid compositions.
It has surprisingly been discovered that the reduction in efficacy afforded by the addition of amphoteric surfactants can be negated by careful selection of the amphoteric component. Amphoteric surfactants are ones which possess a zwitterion. That is to say, part of the molecule incorporates both positively and negatively charged functional groups. The positively charged group is normally centred on a nitrogen atom, whilst the negatively charged group is normally a carboxylic acid group. The most common amphoteric surfactant used in hand soaps is cocamidopropyl betaine. A betaine is a specific type of zwitterion, being a neutral chemical compound with a positively charged cationic functional group, such as a quaternary ammonium or phosphonium cation that bears no hydrogen atom, and a negatively charged functional group, such as a carboxylate group, that may not be adjacent to the cationic site An example of one of the first betaines to be discovered is N,N,Ntrimethylglycine (TMG), shown below for reference: CH,4 0 H3C" 4 -W._ I-13C N,N,N-trimethylglyc ne Whilst not being bound by theory, it is believed that most common amphoteric surfactants, such as those incorporating a betaine group, lose their anionic charge at such low pH by virtue of their carboxylic acid groups becoming protonated. Once the pH is sufficiently acidic for this process to take place, the amphoteric surfactant becomes predominantly cationic in nature. Cationic surfactants are the opposite charge to anionic surfactants and it is believed they inhibit the synergistic effect between the organic acid and the anionic surfactant. However, these behaviours are non-linear and interact with other formulation components and features such as ionic strength to make the effects unpredictable in practice.
In contrast, the particular amphoteric surfactants of the present invention do not derive their anionic groups from carboxylic acids, rather these anionic groups are the result of sulphonate groups which remain ionised at acidic pH. Consequently, the amphoteric surfactants of the present invention do not become cationic in nature in the presence of organic acids and, whilst this is unproven it is speculated that this does not inhibit the synergistic effect between anionic and amphoteric surfactants to the same degree.
This process can be illustrated by changing the amphoteric surfactant to a sultaine. Sultaines are similar to betaines. They have an analogous structure to betaines but with the carboxylic acid group substituted for a sulphonate group, as exemplified by formula I, which shows cocamidopropyl hydroxysultaine below for reference.
0 n H.-o 1
N S
01-4 0 0 cocamidopropyl hydroxysultaine Preferably the at least one amphoteric surfactant is selected from babassuamidopropyl hydroxysultaine, cannabisamidopropyl hydroxysultaine, capryl sultaine, cetyl sultaine, cocamidopropyl hydroxysultaine, coco-hydroxysultaine, coco-sultaine, erucamidopropyl hydroxysultaine, lauramidopropyl hydroxysultaine, lauryl hydroxysultaine, lauryl sultaine, myristamidopropyl hydroxysultaine, myristyl sultaine, oleamidopropyl hydroxysultaine, tallowamidopropyl hydroxysultaineor mixtures thereof Preferably the at least one amphoteric surfactant is a hydroxy sultaine Sultaines do not become cationic in nature in the presence of organic acids and as a result do not inhibit the synergistic effect between anionic and amphoteric surfactants to the same degree. Preferably the at least one amphoteric surfactant is selected from formula I in which n is from 6 to 18, preferably from 8 to 16. The alkyl chain represented by n may be saturated or unsaturated, mono unsaturated is preferred as this may provide higher foaming particularly in combination with n being from 9 to 13.
Preferably the at least one amphoteric surfactant is cocamidopropyl hydroxysultaine.
Cocamidopropyl hydroxysultaine has been demonstrated to show improved bactericidal activity over corresponding betaine-containing cleansing formulations.
Preferably the at least one amphoteric surfactant is present in an amount of 0.1-3.5% w/w. While w/w is defined as the proportion of a particular substance within a mixture, as measured by weight or mass, in this case the skilled person will be aware that it is the mass of the component being referred to. 0.1-3.5 % w/w translates as a composition comprising 0.13.5 grams of solute dissolved in 100 grams of solution.
Preferably the at least one alpha hydroxy acid is selected from citric acid, lactic acid, glycolic acid, malic acid, oxalic acid, carbonic acid, tartaric acid, mandelic acid or mixtures thereof More preferably the alpha hydroxy acid is lactic acid, glycolic acid or mandelic acid, which have been shown to be less inhibited in combination with any anionic surfactant component to improve the mildness (skin-feel) of the formulation produced. More preferably the alpha hydroxy acid is lactic acid, glycolic acid or mandelic acid, which have been shown to be less inhibited in combination with any anionic surfactant component to improve the mildness (skin-feel) of the formulation produced. Most preferably the alpha hydroxy acid is lactic acid or glycolic acid, which have been shown to be less inhibited in combination with any anionic surfactant component to improve the mildness (skin-feel) of the formulation produced. Alternatively, mandelic acid can be preferred due to mildness and foaming in combination with sodium or potassium dodecyl sulphate. Alpha hydroxy acids are known to be good disinfectants and have reasonable skin compatibility to make them useful in personal care applications. A mixture of said acids may be used.
Preferably the at least one alpha hydroxy acid is present in an amount of 0.1-5 °A w/w, further 15 preferably in an amount of 0.5-3 % w/w, and highly preferably in an amount of 0.8-2 % w/w.
Preferably the at least one anionic surfactant comprises an alkyl sulphate group, an ethoxylated alkyl sulphate group, a sulphosuccinate group, a sulphoacetate group, a sarcosinate group, a linear alkyl aryl sulphonate group, a secondary alkane sulphonate group, an alpha olefin sulphonate group, an alkyl phosphate ester group or derivatives thereof More preferably the at least one anionic surfactant is selected from sodium laureth sulphate, sodium lauryl sulphate, sodium lauryl sulphoacetate or mixtures thereof Sodium laureth sulphate, sodium lauryl sulphate and sodium lauryl sulphoacetate may provide synergistic action with alpha hydroxy acids in personal care compositions.
Preferably the at least one anionic surfactant is present in an amount of 2.0-40.0% w/w, further preferably in an amount of 5.0-20 % w/w, and highly preferably in an amount of 7.512.5 % w/w.
Preferably the at least one anionic surfactant and the at least one amphoteric surfactant are present in an amount of 3-20 % w/w, further preferably in an in an amount of 5-15 % w/w. Soaps generally have anionic surfactant and amphoteric surfactants present in amounts of 5-10 % w/w, respectively, although the skilled person will note that the levels of the present invention are raised slightly because the acid inhibits the foaming action.
Preferably the ratio of the at least one anionic surfactant to the at least one amphoteric surfactant is 2:1 or greater, further preferably the ratio of the at least one anionic surfactant to the at least one amphoteric surfactant is 3:1 or greater. Typical formulations have a ratio of the at least one anionic surfactant to the at least one amphoteric surfactant being 3:1 or greater.
Preferably the composition further comprises a hydrolysed wheat protein. A derivative thereof is cocodimonium hydroxypropyl hydrolyzed wheat protein. Hydrolysed wheat proteins are abile to moisturise the skin. Particularly in acid conditions which render the protein molecules slightly cationic.
Preferably the hydrolysed wheat protein is present in an amount of 0.1-1.0% w/w. A hydrolysed wheat protein derivative thereof may be present in an amount of 0.1-1.0 (1/0 w/w.
Preferably the composition has a pH in the range 2-4.8, further preferably in the range from pH 2.5 to 4 and highly preferably in the range from pH 3 to 4.
The carrier or solvent of the liquid cleansing composition may be or may include water.
Water of the liquid cleansing composition may be deionized water, demineralized water, and/or softened water. In an exemplary embodiment, the carrier of the liquid cleansing composition includes demineralized water and softened water. Water may make up the balance of the liquid cleansing composition. The amount of water in the liquid cleansing composition may include free water added and water introduced with other components or materials of the liquid cleansing composition. For example, the amount of the water in the liquid cleansing composition may include free water and water associated with the surfactants or any other component of the liquid cleansing composition. Preferably the composition comprises more than 65% water, more than 80% water, more than 70% water, more than 75% water, more than 80% water, more than 85% water, more than 90% water or more than 95% water.
The liquid cleansing composition may include one or more skin care agents. Any suitable skin care agents that do not adversely affect the stability and/or efficacy of the liquid cleansing composition may be used. In at least one embodiment, the skin care agent may include an emollient configured to maintain a soft, smooth, and pliable appearance to the skin. As is known by those skilled in the art, the emollients may function by remaining on the surface of the skin or in the stratum corneum to act as a lubricant, to reduce flaking, and/or to improve the appearance of the skin.
The skin care agents may generally include one or more polymers (e.g., polyvinylpyrrolidine), protein derivatives (e.g., hydrolyzed wheat protein, derivatized hydrolyzed wheat protein such as cocodimonium hydroxypropyl hydrolyzed wheat protein), ethoxylated fatty ethers, cellulosics (e.g., hydroxyethylcellulose) and combinations thereof Illustrative skin care agents may include, but are not limited to, esters comprising an aliphatic alcohol having about 2 to about 18 carbon atoms condensed with an aliphatic or aromatic carboxylic acid including about 8 to about 20 carbon atoms (e.g., isopropyl myristate, decyl oleate-or ethyl hexyl glycerine etc.). The esters may be straight chained or branched. In a preferred embodiment, the ester has a molecular weight of less than about 500 Daltons.
Other skin care agents may include, but are not limited to, polyvinyl-pyrrolidone, polyquaternium-4, polyquatemium-7, polyquaternium-10, guar gum derivatives, hydroxypropylmethylcellulose, hydroxyethyl cellulose, a polyethylene glycol, a methyl ether of a polyethylene glycol, quaternium-79, wheat germamidopropyl hydroxypropyl dimonium hydrolyzed wheat protein, stearyl methicone, dimethicone copolyol, dimethicone propyl PG betaine, poly(sodium styrene sulfonate), sorbitan oleate, steareth-2, steareth-21, isoceteth-20, PEG-7 glyceryl cocoate, PEG-75 lanolin, glycereth-26, PPG-5-ceteth-20, a C12-C20 alcohol, canola oil, glyceryl laurate, triglyceryl monostearate, glyceryl monostearate, vitamin E acetate, sunflower seed amidopropylethyldimonium ethylsulfate, sodium PEG-7 olive oil carboxylate, PPG-1 hydroxy ethyl caprylamide, PPG-2 hydroxy ethyl cocamide, mineral oil, petrolatum, aloe barbadensi s, i sostearami dopropylm orpholine lactate, strontium acetate, palmitamidopropyltrimonium chloride and combinations thereof The preferred skin care agent is hydrolysed wheat protein. The skin care agent may be a derivative of hydrolysed wheat protienPreferably quatemized wheat protein. Most preferably the skin care agent is the is cocodimonium hydroxypropyl hydrolyzed wheat protein, which has been found to be particularly mild, such as in providing lower skin irritancy.
The liquid cleansing composition may include one or more additional optional ingredients. Illustrative optional ingredients may include, but are not limited to, one or more dyes, fragrances or perfuming agents, buffers and buffering agents (e.g., inorganic phosphates, sulfates, and carbonates), pH adjusters (e.g., acids and/or bases), non-ionic surfactants, preservatives (e.g., parabens, sodium salicylate, sodium benzoate, etc.), thickeners, viscosity adjusters, water softeners, pearlising agents, essential oils, exfoliants, emollients, antioxidants, foam enhancers, chelating agents (e.g., EDTA, phosphates, etc.), °pacifiers, hydric solvents, hydrotropes, humectants, antimicrobials and combinations thereof Preferably the composition comprises an emollient ester selected from isopropyl mynstate, decyl oleate or ethyl hexyl glycerine.
Basic pH adjusters may include ammonia; mono-, di-, and tri-alkyl amines; mono-, di-, and tri-alkanolamines, alkali metal and alkaline earth metal hydroxides and combinations thereof For example, the basic pH adjuster may be ammonia, sodium hydroxide, potassium hydroxide, lithium hydroxide, monoethanolamine, triethylamine, isopropanolamine, diethanolamine, triethanolamine and combinations thereof Acidic pH adjusters may include mineral acids and polycarboxylic acids. The mineral acids may be or include hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid and combinations thereof. The polycarboxylic acids may be or include citric acid, glycolic acid, lactic acid and combinations thereof.
Non-ionic surfactants may be or include amine oxides, alkyl polyglycosides, polysorbate 20, poloxamer 407, poloxamer 338, poloxamer 124 or mixtures thereof The non-ionic surfactants may also include, but are not limited to, ethoxylated and hydrogenated ethoxylated castor oils, such as those commonly designated as PEG NN castor oil or PEG NN hydrogenated castor oil, where "NN" designates the number of ethylene oxide units polymerized onto the castor oil to form the non-ionic surfactant For example, the non-ionic surfactants may be or include PEG 16, 20, 25, 30, 40, 50, 60, 80, 100, 200, and combinations thereof.
The liquid cleansing composition may have an acidic pH. In a preferred embodiment, the liquid cleansing composition is at least partially acidic. For example, the liquid cleansing composition may have a pH less than 7. In another example, the liquid cleansing composition may have a pH greater than or equal to 1 and less than 7. In a preferred embodiment, the liquid cleansing composition has a pH from 2 to 4.8, further preferably in the range from pH 2.5 to 4 and highly preferably in the range from pH 3 to 4.
Foam enhancers may be or include, but is not limited to, cocamide MEA (i.e., cocamide monoethanolamide), cocamide DEA, soyamide DEA, lauramide DEA, oleamide MIPA, stearamide MEA, myristamide MEA, lauramide MEA, capramide DEA, ricinoleamide DEA, myristamide DEA, stearamide DEA, oleylamide DEA, tallowamide DEA, lauramide MTPA, tallowamide MEA, isostearamide DEA, isostearamide MEA, and the like, and combinations thereof.
Humectants may be or include, but are not limited to, ascorbic acid, ascorbyl dipalmitate, acetamide MEA, glucose glutamate, glucuronic acid, TEA-lactate, TEA-PCA, corn syrup, fructose, glucose, glycerin, glycol, 1,2,6-hexanetriol, sodium lactate, sodium PC A, hydrogenated starch hydrolysate, inositol, lactic acid, lactose, mannitol, PC A, PEG-10 propylene glycol, polyamino sugar condensate, propylene glycol, pyridoxine dilaurate, saccharide hydrolysate, hydroxystearyl methyl glucamine, glucamine, maltitol, mannitol, methyl gluceth-10, methyl gluceth-20, riboflavin, PEG-4, PEG-6, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18, PEG-20, PEG-32, PEG-40, glutamic acid, glycereth-7, glycereth-12, glycereth-26, saccharide isomerate, sorbeth-20, sorbitol, sucrose, thioglycerin, tris-(hydroxymethyl)nitromethane, tromethamine, hi stidine, PEG-75, PEG-135, PEG-150, PEG-200, PEG-5 pentaerythritol ether, polyglyceryl sorbitol, sorbitol, urea, xylitol and combinations thereof
Examples
Examples were prepared according to Table I. Comparative Examples are denoted as Cl, C2, C3 etc. and Inventive Examples are denoted simply as El, E2 etc. For the avoidance of any doubt, all amounts are expressed as % w/w with the remainder of the composition of each formulation being water.
Component Identity Examples CI C2 I C3 El E2 Anionic Sodium laureth 6.8 6.8 6.8 6.8 6.8 surfactant sulphate Anionic Sodium lauryl 2.2 2.2 2.2 2.2 2.2 surfactant sulphate Amphoteric Cocamidopropyl 0 2.8 0 0 0 surfactant betaine Amphoteric Sodium 0 0 2.8 0 0 surfactant cocoamphoacetate Amphoteric Cocamidopropyl 0 0 0 2.8 2.8 surfactant hydroxysultaine Alpha Lactic acid 1.5 1.5 1.5 1.5 0 hydroxy acid Alpha Glycolic acid 0 0 0 0 1.5 hydroxy acid pH adjuster Sodium To pH To pH To pH To pH To pH hydroxide 3.4 -3.6 3.4 -3.6 3.4 -3.6 3.4 -3.6 3.4 -3.6 EN 1276 E. Coli 60-second >5.32 < 1.95 < 1.95 > 5.32 > 5.29 contact time (pass) (fail) (fail) (pass) (pass) Log reduction Table 1 Formulations prepared Tests were conducted in accordance with BS EN 1276:2019. This is the British and European quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas. Samples of the product were diluted, which in the case of hand soap products is with equal parts hard water. These solutions are then mixed with a suspension of bacteria (selected from Pseztdornonas aeruginosa, Escherichia coil KI2, Staphylococcus aureus and Enterococcus hirae) in a solution of an interfering substance. The mixture is maintained at the test temperature (20°C) for a given contact time, which in the case of hand soap products is no greater than 1 minute. After the given contact time, an aliquot is taken and the active ingredients in the portion are immediately neutralised, to prevent further biocida1 action outside of the given contact time, and the numbers of surviving bacteria are enumerated. The efficacy of the disinfectant is calculated by subtracting the numbers of surviving bacteria from the number of cells in the test mixture at the beginning of the contact time. In the case of a bactericidal hand soap, the pass criteria stipulate that at least a log 3 reduction of the bacteria must be achieved.
Examples CI-C3 differ by way of choice of amphoteric surfactant used. Based upon the results for the two comparative examples CI-C3, it quickly becomes apparent that addition of an amphoteric surfactant to an acidified solution of anionic surfactant inhibits the biocida1 action. Turning to Inventive Examples El and E2, cocamidopropyl hydroxysultaine is used as a like for like replacement for cocamidopropyl betaine where an improved EN 1276 E. Coli 60-second contact time Log reduction is obtained. The selection of different alpha hydroxy acids is also demonstrated by Examples El and E2. The skilled formulator will note that whilst the careful use of the correct amphoteric surfactant modifies the properties of the anionic surfactant(s) to produce a desirable formulation, it would be especially desirable to also negate the negative effects of organic acids on the skin. In order to demonstrate this by way of Example, further Inventive Examples, E3 and E4, were prepared according to Table 2 below, where principle to negating the effects of organic acids is the use of hydrolysed wheat proteins and their derivatives as demonstrated. Again, for the avoidance of any doubt, all amounts are expressed as % w/w with the remainder of the composition of each formulation being water.
Component Identity Examples E3 E4 Anionic surfactant Sodium laureth 6.8 6.8 sulphate Anionic surfactant Sodium lauryl 2.2 2.2 sulphate Amphoteric surfactant Cocamidopropyl 2.8 2.8 hydroxysultaine Alpha hydroxy acid Lactic acid 1.5 1.5 Additional biocide Phenoxyethanol 1 1 Skin conditioner Quaternized wheat 1 0 protein Perfume Perfume 0.6 0.6 pH adjuster Sodium hydroxide To p113.1 -3.3 To pH 3.1 -3.3 EN 1276 E. Coll 3.98 (pass) >4.48 (pass) 60-second contact time Log reduction Table 2 Additional formulations prepared Hydrolysed wheat proteins are well known for their ability to moisturise the skin, particularly in such acid conditions which render the protein molecules slightly cationic and therefore more substantive to the skin. Beneficial are the quaternized variants which have permanent cationic charges which endow the molecules with further substansivity.
As is expected from the aforementioned teachings, such molecules have a deleterious effect on efficacy by negatively interacting with the anionic surfactants, as can be seen from the S corresponding data for EN 1276 E Coli 60-second contact time Log reduction values demonstrated in Table 2.
The correct choice of amphoteric surfactant therefore brings the desired increase in sensory characteristics, such as mildness and foaminess, without such deleterious effects on efficacy.
Such a high underlying efficacy of the formulation enables minor additions of other desirable substances which, whilst having a slightly deleterious effect on efficacy, can substantially reduce the irritation potential of the organic acid to make a commercially viable formulation.
Claims (2)
- Claims: A liquid cleansing composition comprising: at least one alpha hydroxy acid; at least one anionic surfactant; a hydrolysed wheat protein and at least one amphoteric surfactant; wherein the at least one amphoteric surfactant comprises a sultaine group.
- 2. The composition of claim 1, wherein the at least one amphoteric surfactant is selected from babassuamidopropyl hydroxysultaine, cannabisamidopropyl hydroxysultaine, capryl sultaine, cetyl sultaine, cocamidopropyl hydroxysultaine, coco-hydroxysultaine, cocosultaine, erucamidopropyl hydroxysultaine, lauramidopropyl hydroxysultaine, lauryl hydroxysultaine, lauryl sultaine, myristamidopropyl hydroxysultaine, myristyl sultaine, oleamidopropyl hydroxysultaine, tallowamidopropyl hydroxysultaine or mixtures thereof 3. The composition of claim 1 or claim 2, wherein the at least one amphoteric surfactant is a hydroxy sultaine.4. The composition of any of claim 1 to claim 3, wherein the at least one amphoteric surfactant is cocamidopropyl hydroxysultaine.5. The composition of any preceding claim, wherein the at least one amphoteric surfactant is present in an amount of 0.1-3.5 % w/w.6. The composition of any preceding claim, wherein the at least one alpha hydroxy acid is selected from citric acid, lactic acid, glycolic acid, malic acid, oxalic acid, carbonic acid, mandelic acid or mixtures thereof 7. The composition of claim 6, wherein the at least one alpha hydroxy acid is lactic acid, glycolic acid or mandelic acid.8. The composition of any preceding claim, wherein the at least one alpha hydroxy acid is present in an amount of 0.1-5 % w/w.9 The composition of any preceding claim, wherein the at least one anionic surfactant comprises a sulphosuccinate group, a sulphoacetate group or derivatives thereof 10. The composition of any of claim 1 to claim 8, wherein the at least one anionic surfactant is selected from sodium laureth sulphate, sodium lauryl sulphate, sodium lauryl sulphoacetate or mixtures thereof 11. The composition of any preceding claim, wherein the at least one anionic surfactant is present in an amount of 20-40.0% w/w.12 The composition of any preceding claim, wherein the at least one anionic surfactant and the at least one amphoteric surfactant are present in an amount of 3-20 % w/w.13. The composition of claim 12, wherein the at least one anionic surfactant and the at least one amphoteric surfactant are present in an amount of 5-15 % w/w.14. The composition of any preceding claim, wherein the ratio of the at least one anionic surfactant to the at least one amphoteric surfactant is 2:1 or greater.15. The composition of claim 14, wherein the ratio of the at least one anionic surfactant to the at least one amphoteric surfactant is 3:1 or greater.16. The composition of claim 1, wherein the hydrolysed wheat protein is present in an amount of 0.1-1.0% w/w.17 The composition of any preceding claim, having a pH in the range 2-4.8 18. The composition of any preceding claim, further comprising one or more additional ingredients selected from one or more dyes, fragrances, perfuming agents, buffers and buffering agents, pH adjusters, non-ionic surfactants, preservatives, thickeners, viscosity adjusters, water softeners, pearlising agents, essential oils, exfoliants, emollients, antioxidants, foam enhancers, chelating agents, opacifiers, hydric solvents, hydrotropes, humectants, antimicrobials and combinations thereof 19 The composition of claim 18, comprising an emollient ester selected from isopropyl myri state, decyl oleate or ethyl hexyl glycerine.The composition of any preceding claim, wherein the balance of the composition is water.21. The composition of any preceding claim, wherein the composition comprises more than 80% water.22 The composition of any preceding claim, wherein the composition consists of the specified components and any solvent
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2317800.7A GB2621755A (en) | 2021-04-16 | 2021-04-16 | Liquid cleansing composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2317800.7A GB2621755A (en) | 2021-04-16 | 2021-04-16 | Liquid cleansing composition |
GB2105468.9A GB2605843B (en) | 2021-04-16 | 2021-04-16 | Liquid cleansing composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB2621755A true GB2621755A (en) | 2024-02-21 |
Family
ID=76377750
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2317800.7A Pending GB2621755A (en) | 2021-04-16 | 2021-04-16 | Liquid cleansing composition |
GB2105468.9A Active GB2605843B (en) | 2021-04-16 | 2021-04-16 | Liquid cleansing composition |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2105468.9A Active GB2605843B (en) | 2021-04-16 | 2021-04-16 | Liquid cleansing composition |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB2621755A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024092386A1 (en) * | 2022-10-31 | 2024-05-10 | L'oreal | A cleansing composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0761205A1 (en) * | 1995-08-19 | 1997-03-12 | Kao Corporation | Hair shampoo |
WO2017174675A1 (en) * | 2016-04-08 | 2017-10-12 | Rhodia Operations | Personal care compositions and methods for using such compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7544366B1 (en) * | 2002-12-03 | 2009-06-09 | Permamed Ag | Method and skin cleansing compositions for dermatological basic treatment |
KR100831594B1 (en) * | 2007-02-20 | 2008-05-23 | 주식회사 닥터비 아토키즈 랩 | Weak acid cleansing cosmetic composition containing oriental herb extract for atopy skin |
US20110142965A1 (en) * | 2009-12-10 | 2011-06-16 | Bob Walke | Skin moisturizer and washing formulation |
US8329626B2 (en) * | 2010-06-24 | 2012-12-11 | Johnson & Johnson Consumer Companies, Inc. | Low-irritating, clear cleansing compositions with relatively low pH |
-
2021
- 2021-04-16 GB GB2317800.7A patent/GB2621755A/en active Pending
- 2021-04-16 GB GB2105468.9A patent/GB2605843B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0761205A1 (en) * | 1995-08-19 | 1997-03-12 | Kao Corporation | Hair shampoo |
WO2017174675A1 (en) * | 2016-04-08 | 2017-10-12 | Rhodia Operations | Personal care compositions and methods for using such compositions |
Also Published As
Publication number | Publication date |
---|---|
GB2605843B (en) | 2024-01-03 |
GB202105468D0 (en) | 2021-06-02 |
GB2605843A (en) | 2022-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016416435B2 (en) | Liquid cleansing compositions with an antibacterial system and method of manufacturing thereof | |
EP0762868B1 (en) | Mild antimicrobial liquid cleansing formulations | |
KR100320688B1 (en) | Liquid Cleansing Formulations | |
AU2013240278A1 (en) | Cationic antimicrobial handwash | |
EP0907355A1 (en) | Skin wash compositions comprising triclocarban and surfactants | |
AU2010365063A1 (en) | Liquid cleaning compositions containing long-chain fatty alcohols | |
US20130172415A1 (en) | Triclosan-free antibacterial soap | |
GB2621755A (en) | Liquid cleansing composition | |
CN109562041B (en) | Solid cleaning compositions with taurine and methods thereof | |
US11517512B2 (en) | Personal care compositions comprising zinc : usnic acid complexes and methods of use | |
CN115252448A (en) | Bacteriostatic personal cleaning composition and application thereof | |
US20240189203A1 (en) | Liquid Personal Care Compositions and Methods for the Same | |
RU2806238C2 (en) | Preservation systems and compositions containing them | |
US20230381068A1 (en) | Personal care compositions | |
US20240358605A1 (en) | Personal care compositions | |
CA3130840A1 (en) | Alkaline disinfecting compositions |